Walter Reed Receives FDA Clearance for 3D-Printed Titanium Cranial Implants

First Point-of-Clearance for 3D Printed Cranial Implants

The 3D Medical Applications Center at Walter Reed National Military Medical Center has received FDA 510(k) premarket clearance for its Titanium Cranial Plate System. The clearance, filed under submission number K253116, marks the first time the FDA has cleared an implant specifically for a point-of-care institution. It is also the first FDA-cleared medical device produced by the 3D MAC itself.

The patient-specific titanium plates reconstruct complex cranial and facial defects caused by trauma, disease, or cancer. The system targets active duty personnel and war fighters with traumatic head injuries. Dr. Peter Liacouras, director of services at the 3D MAC, led the design work. The center has been using medical 3D printing since the late 1990s and was formally established in the early 2000s.

Built-In Fixation Speeds Surgery

The TCP System's distinguishing feature is that the fixation bars are incorporated directly into the plate design. Surgeons can place the implant and screw it down without separate fixation hardware. The team plans fixation locations using CT scans and 3D reconstructions, then manufactures the plates in-house. That workflow cuts down on lead time compared to outsourcing implants to third-party manufacturers.

A First-of-Its-Kind Regulatory Path

The 510(k) clearance follows work that began in 2020, when Liacouras started coordinating with Dr. Beth Ripley at the VA Puget Sound Health Care System. Anticipating tighter FDA oversight of point-of-care printing, they secured funding to build quality management systems at both sites. The Defense Health Agency's Office of Regulated Activities sponsored the submission, which cleared on the first attempt. That is an unusual outcome for a first-time submitter, according to biomedical engineer Nikki McMinn.

3D Systems supported the multi-year effort, contributing process controls, device design optimization, additive manufacturing workflows, and regulatory strategy. Natalie Byrnes, Manager of Product Development for Patient Specific Medical Technology at 3D Systems, said the clearance underscores the value of combining clinical innovation with additive manufacturing expertise.

What Comes Next

The 3D MAC is already developing a PEEK implant as a non-metallic alternative, along with a custom titanium ridge augmentation matrix for dental implant planning. Liacouras also plans to enroll other military facilities as contract designers under the 3D MAC's quality management system, sending design files to Walter Reed for centralized manufacturing.

For the additive manufacturing industry, the clearance is a concrete example of point-of-care 3D printing moving from experimental to regulated production. It also shows that clinical sites can carry the quality infrastructure needed for FDA submissions without relying entirely on outside manufacturers.